date:Apr 22, 2014
ual name of the ingredient at issue and that the FDA is engaged in active rulemaking on the issue.
But not all district court judges are following Judge Illstons reasoning, according to Arnold (Arnie) I. Friede, a food and drug law attorney with Sandler Travis Rosenberg and a former associate chief counsel in FDAs Chief Counsels Office.
Given the divergence of views by different district court judges on whether ECJ cases should be dismissed on primary jurisdiction grounds, it seems reasonable